Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEDELSIS is a private Turkish medical device company focused on ophthalmology. The company says it works with ophthalmologists to provide sophisticated instruments for diagnosing and treating ocular diseases, with an emphasis on engineering, configuration, service, and after-sales support rather than drug development. Founded in Ankara in April 2006, it appears to operate commercially and to serve customers across Africa, Eastern Europe, the Middle East, and Western Asia. Available public information suggests MEDELSIS is a healthcare equipment supplier rather than a biotech or pharmaceutical developer, and no therapeutic pipeline or clinical-stage assets were identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEDELSIS.